EUVIMEDEUVIMED entdecken
Crossref

Enterovirus A71 2A‐S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines

Peng Zhang, Wenjia Zou, Rui Xiong, Yong Wu, Changfa Fan, Yihong Peng

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Peng Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. Hauptthemen laut MEDLINE: Enterovirus A, Human, Enterovirus Infections, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key R&D Program of China under Grant number 2021YFC230170104, National Natural Science Foundation of China under Grant number 81974310.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enteroviruses are important human pathogens with diverse serotypes, posing a major challenge to develop vaccines for individual serotypes, the success of polio vaccines in controlling and eradicating polio, along with the recent emergence and high prevalence of enterovirus‐caused infectious diseases, highlights the importance of enterovirus vaccine development. Given our previous report on enteroviruses weakened by the 2 A S/T125A mutation, we assessed the potential of the EV‐A71 2A‐125A mutant as a vaccine candidate to address this challenge. We found that the 2A‐125A mutant caused transient mild symptoms, low viral loads, and no significant pathological changes mild pathological changes in hSCARB2‐KI mice, producing long‐lasting cross‐neutralizing antibodies against two EV‐A71 wild strains. Pre‐exposure to the 2A‐125A mutant substantially protected against the EV‐A71 Isehara wild‐type strain, causing minor pathologies, significantly reducing muscle and lung inflammation, and preventing neurological damage, with reduced viral loads in vivo. Pre‐exposure also distinctly suppressed the expression of pro‐inflammatory cytokines, correlating to the severity of clinical symptoms. Collectively, the EV‐A71 2A‐125A mutant was attenuated and could generate a robust and protective immune response, suggesting its potential as a vaccine candidate and global solution for specific enterovirus vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterovirus A, HumanEnterovirus InfectionsAntibodies, NeutralizingAntibodies, ViralViral VaccinesViral LoadVaccines, AttenuatedAnimalsMiceHumansVaccine DevelopmentFemaleMutationCytokines

Stichwörter der Autor:innen

EV‐A71 mutantenterovirusesimmune responseserotype‐specific vaccinesviral pathogenesis

Substanzen

Antibodies, NeutralizingAntibodies, ViralViral VaccinesVaccines, AttenuatedCytokines

Autor:innen und Institutionen

  • Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, China.

Förderung

  • National Key R&D Program of China under Grant number 2021YFC230170104
  • National Natural Science Foundation of China under Grant number 81974310

Zitieren

APA

Zhang, P., Zou, W., Xiong, R., Wu, Y., Fan, C., & Peng, Y. (2024). Enterovirus A71 2A‐S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines. Journal of Medical Virology. https://doi.org/10.1002/jmv.29838

Vancouver

Zhang P, Zou W, Xiong R, Wu Y, Fan C, Peng Y. Enterovirus A71 2A‐S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines. Journal of Medical Virology. 2024. doi:10.1002/jmv.29838

BibTeX
@article{Zhang2024,
  author = {Zhang, Peng and Zou, Wenjia and Xiong, Rui and Wu, Yong and Fan, Changfa and Peng, Yihong},
  title = {Enterovirus A71 2A‐S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29838}
}
Kostenlos starten →